# Low Dose Bismuth Versus Lactobacillus Reuteri for H. Pylori Eradication

> **NCT03925818** · NA · TERMINATED · sponsor: **Università degli Studi di Sassari** · enrollment: 99 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Bismuth Subcitrate Potassium
- **DIETARY_SUPPLEMENT:** Gastrus

## Key facts

- **NCT ID:** NCT03925818
- **Lead sponsor:** Università degli Studi di Sassari
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-08-29
- **Primary completion:** 2018-11-29
- **Final completion:** 2018-12-23
- **Target enrollment:** 99 (ACTUAL)
- **Why stopped:** Lactobacillus reuteri (Gastrus®) was not anymore available in the region
- **Last updated:** 2019-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03925818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03925818, "Low Dose Bismuth Versus Lactobacillus Reuteri for H. Pylori Eradication". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT03925818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*